Stereotactic body radiotherapy for low-risk prostate cancer: five-year outcomes

PURPOSE: Hypofractionated, stereotactic body radiotherapy (SBRT) is an emerging treatment approach for prostate cancer. We present the outcomes for low-risk prostate cancer patients with a median follow-up of 5 years after SBRT. METHOD AND MATERIALS: Between Dec. 2003 and Dec. 2005, a pooled cohort...

Descripción completa

Detalles Bibliográficos
Autores principales: Freeman, Debra E, King, Christopher R
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3022740/
https://www.ncbi.nlm.nih.gov/pubmed/21219625
http://dx.doi.org/10.1186/1748-717X-6-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3022740/
https://www.ncbi.nlm.nih.gov/pubmed/21219625
http://dx.doi.org/10.1186/1748-717X-6-3

Ejemplares similares